Robert D. Lister) - 07 Nov 2025 Form 4 Insider Report for IMAX CORP (IMAX)

Role
Chief Legal Officer Sr Exec VP
Signature
/s/ Kenneth I. Weissman (attorney-in-fact for Robert D. Lister)
Issuer symbol
IMAX
Transactions as of
07 Nov 2025
Net transactions value
-$1,738,217
Form type
4
Filing time
07 Nov 2025, 16:07:43 UTC
Previous filing
15 Sep 2025
Next filing
12 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
LISTER ROBERT D Chief Legal Officer Sr Exec VP 902 BROADWAY, 20TH FLOOR, NEW YORK /s/ Kenneth I. Weissman (attorney-in-fact for Robert D. Lister) 07 Nov 2025 0001255900

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMAX common shares Conversion of derivative security $1,127,716 +50,143 +31% $22.49 211,564 07 Nov 2025 Direct F1
transaction IMAX common shares Sale $1,738,217 -50,143 -24% $34.67 161,421 07 Nov 2025 Direct
holding IMAX common shares (opening balance) 161,421 07 Nov 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMAX stock options (to buy) Conversion of derivative security $1,127,716 -50,143 -100% $22.49 0 07 Nov 2025 common shares 50,143 $22.49 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Represents the conversion upon exercise of stock options into common shares, pursuant to a 10b5-1 Plan dated June 11, 2025.
F2 These options were issued in 2019 and are set to expire on March 7, 2026.
F3 The stock options became exercisable in four installments: 12,535 on each of March 7, 2020, March 7, 2021 and March 7, 2022 and 12,538 on March 7, 2023.
F4 Mr. Lister's aggregate remaining restricted share unit and common share balances following these transactions will be 70,609 and 161,421, respectively.